Digitally Enabled Remote Glaucoma Care | Max Ostermeier

Digitally Enabled Remote Glaucoma Care

Max Ostermeier
Co-founder & CEO, Implandata Ophthalmic Products GmbH

Max G. Ostermeier is a co-founder and the CEO of Implandata Ophthalmic Products GmbH. He has extensive experience in the commercial development of technologically advanced products, in building operational capabilities for aggressively growing companies and in creating businesses, attracting potential acquirers in the global market.

As serial entrepreneur he was founder and General Manager of Odicrain GmbH, a German medical device start-up, developing a new to the world portable medical device for rapid detection of intracranial bleedings, which was acquired by a US based company in 2007. Mr. Ostermeier was also co-founder and CEO of Cranium Telemetrics GmbH, a medical technology company with innovative neuro surgical products whose technology was acquired 4 year after foundation by a leading US medical device company. Prior to that he was instrumental in creating for a globally leading fine chemistry company their biotech entity, where he served as General Manager and Vice-President until this company was acquired by Sigma Aldrich.

Implandata Ophthalmic Products GmbH is a digital health company, based in Hannover Germany. With our transformative products and solutions we are addressing a vastly underserved need in care of glaucoma patients, by combining innovative medical technology with state of the art information technology. By this we are creating transformative solutions for better and more efficient glaucoma therapy, to the benefit of glaucoma patients and their families.

Our eyemate® system offers eye care specialists proactive and personalized therapy guidance at glaucoma patients. Patients will be closely involved in successful management of their disease by the provision of actionable information via eyemate®.

Implandata Ophthalmics Products GmbH has a team of very experienced and highly motivated experts in their field and is supported by seasoned investors and renown clinical and scientific advisors. We collaborate with prestigious institutes in order to present the most advanced and utile products to patients and the medical community. And we all have the goal to contribute with our products to better glaucoma care and by this sustain quality of life for patients and their families.